Augmedix, Inc. - Common Stock (AUGX)
2.3500
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 28th, 4:18 AM EDT
Detailed Quote
| Previous Close | 2.350 |
|---|---|
| Open | - |
| Bid | 2.340 |
| Ask | 2.390 |
| Day's Range | N/A - N/A |
| 52 Week Range | N/A - N/A |
| Volume | 0 |
| Market Cap | 63.73M |
| PE Ratio (TTM) | -5.000 |
| EPS (TTM) | -0.5 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
About Augmedix, Inc. - Common Stock (AUGX)
Augmedix Inc is a healthcare technology company that develops solutions aimed at enhancing clinician productivity and improving patient care through the use of augmented reality and artificial intelligence. By leveraging real-time documentation capabilities, the company's platform enables healthcare professionals to focus more on patient interaction while simplifying the administrative burden associated with electronic health records. Augmedix collaborates with various healthcare providers to deliver innovative tools that streamline workflow and enhance clinical efficiency, ultimately aiming to transform the healthcare experience for both providers and patients. Read More
News & Press Releases
In a monumental shift for the healthcare industry, machine learning (ML) applications are rapidly being integrated into triage systems, promising to redefine how patients are prioritized and managed. As of October 2025, these intelligent systems are moving beyond experimental phases, demonstrating significant immediate impact in alleviating emergency department (ED) overcrowding, enhancing patient safety, and optimizing [...]
Via TokenRing AI · October 27, 2025

NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · September 12, 2024

NEW YORK, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · September 7, 2024

Augmedix is one of today's big winners in the market, with AUGX stock soaring on news the company will be acquired.
Via InvestorPlace · July 19, 2024

AUGX stock results show that Augmedix missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024
Here are three stocks to sell for investors who may want to seek out speculative opportunities in this difficult to digest market.
Via InvestorPlace · July 25, 2024

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
By Halper Sadeh LLC · Via GlobeNewswire · July 24, 2024

Via Benzinga · July 19, 2024
Augmedix to be acquired by Commure, Inc. for $139 million in equity. Augmedix stockholders to receive $2.35 per share. The acquisition enhances AI medical documentation solutions, boosting efficiency for healthcare providers.
Via Benzinga · July 19, 2024

Via Benzinga · July 19, 2024

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Augmedix, Inc. (NASDAQ: AUGX) to Commure, Inc. for $2.35 per share in cash is fair to Augmedix shareholders.
By Halper Sadeh LLC · Via Business Wire · July 19, 2024

Via Benzinga · May 14, 2024

Via Benzinga · May 14, 2024

Augmedix stock is down on Tuesday as investors in AUGX shares are unimpressed with the company's updated revenue outlook for 2024!
Via InvestorPlace · May 14, 2024

Via Benzinga · May 14, 2024

Via Benzinga · May 14, 2024

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Tuesday morning!
Via InvestorPlace · May 14, 2024

AUGX stock results show that Augmedix beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 13, 2024

Via Benzinga · May 13, 2024

Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here.
Via InvestorPlace · April 19, 2024



